Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiency Disorders (PID)”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Large-scale testing (Phase 3)Study completedNCT00391131
What this trial is testing

Subcutaneous Ig NextGen 16% in PID Patients

Who this might be right for
Primary Immunodeficiency (PID)
CSL Limited 35
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Not applicableStudy completedNCT03716700
What this trial is testing

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 126
Large-scale testing (Phase 3)Study completedNCT01461018
What this trial is testing

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 22
Large-scale testing (Phase 3)Study completedNCT01412385
What this trial is testing

Immune Globulin Subcutaenous (Human), 20%

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 55
Post-approval studies (Phase 4)Study completedNCT00520494
What this trial is testing

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

Who this might be right for
Common Variable ImmunodeficiencyAgammaglobulinemia
CSL Behring 18
Large-scale testing (Phase 3)Study completedNCT01012323
What this trial is testing

NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases
Octapharma 51
Large-scale testing (Phase 3)Study completedNCT00538915
What this trial is testing

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Who this might be right for
Primary Immune Deficiency Disorders (PIDD)
ADMA Biologics, Inc. 63
Large-scale testing (Phase 3)Study completedNCT01313507
What this trial is testing

High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)

Who this might be right for
Primary Immunodeficiency Disease
Octapharma 21
Large-scale testing (Phase 3)Active Not RecruitingNCT06076642
What this trial is testing

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 53
Large-scale testing (Phase 3)Study completedNCT05513586
What this trial is testing

Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 15
Post-approval studies (Phase 4)Study completedNCT02180763
What this trial is testing

Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps

Who this might be right for
Primary Immunodeficiency (PID)
Octapharma 31
Testing effectiveness (Phase 2)Study completedNCT03330795
What this trial is testing

Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant

Who this might be right for
Primary ImmunodeficiencyPID
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableStudy completedNCT01859754
What this trial is testing

Octagam 5% Versus Comparator Post Marketing Trial

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 623
Not applicableActive Not RecruitingNCT04354129
What this trial is testing

Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

Who this might be right for
Primary Immune Deficiency DisorderSecondary Immune Deficiency
University of Alberta 36
Testing effectiveness (Phase 2)Study completedNCT00161993
What this trial is testing

Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)

Who this might be right for
Primary Immunodeficiency Diseases (PID)AgammaglobulinemiaHypogammaglobulinemia
Baxalta now part of Shire 24
Large-scale testing (Phase 3)Looking for participantsNCT07346859
What this trial is testing

Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency Diseases
Biopharma Plasma LLC 56
Large-scale testing (Phase 3)Study completedNCT00419341
What this trial is testing

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Who this might be right for
Primary Immune Deficiency
CSL Behring 49
Large-scale testing (Phase 3)Study completedNCT00680446
What this trial is testing

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency
CSL Limited 41
Testing effectiveness (Phase 2)Study completedNCT00782106
What this trial is testing

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 11
Load More Results